首页> Blood> PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation.

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation.

导出 OA

翻译打印收藏纠错

第一作者： Philippe,Armand

第一单位： Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

作者： Philippe,Armand ^[1] ; Yi-Bin,Chen ^[2] ; Robert A,Redd ^[3] ; Robin M,Joyce ^[4] ; Jad,Bsat ^[1] ; Erin,Jeter ^[1] ; Reid W,Merryman ^[1] ; Kimberly C,Coleman ^[1] ; Parastoo B,Dahi ^[5] ; Yago,Nieto ^[6] ; Ann S,LaCasce ^[1] ; David C,Fisher ^[1] ; Samuel Y,Ng ^[1] ; Oreofe O,Odejide ^[1] ; Arnold S,Freedman ^[1] ; Austin I,Kim ^[1] ; Jennifer L,Crombie ^[1] ; Caron A,Jacobson ^[1] ; Eric D,Jacobsen ^[1] ; Jeffrey L,Wong ^[1] ; Sanjay S,Patel ^[7] ; Jerome,Ritz ^[1] ; Scott J,Rodig ^[7] ; Margaret A,Shipp ^[1] ; Alex F,Herrera ^[8]

作者单位： Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. ^[1] Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA. ^[2] Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA. ^[3] Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA. ^[4] Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. ^[5] Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX. ^[6] Department of Pathology, Brigham and Women's Hospital, Boston, MA; and. ^[7] Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA. ^[8]

医学主题词成年人(Adult);老年人(Aged);无病生存(Disease-Free Survival);女(雌)性(Female);造血干细胞移植(Hematopoietic Stem Cell Transplantation);霍奇金病(Hodgkin Disease);人类(Humans);男(雄)性(Male);中年人(Middle Aged);挽救疗法(Salvage Therapy);移植, 自体(Transplantation, Autologous)

DOI 10.1182/blood.2019000215

PMID 30952672

发布时间 2024-09-22

基金项目

P30 CA016672/CA/NCI NIH HHS/United States T32 HL007627/HL/NHLBI NIH HHS/United States R01 CA161026/CA/NCI NIH HHS/United States P30 CA008748/CA/NCI NIH HHS/United States K12 CA001727/CA/NCI NIH HHS/United States P50 CA107399/CA/NCI NIH HHS/United States

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交